TAIPY   $10.57  5.70% Market Closed

Taisho Pharmaceutical Holdings
Total Cash 266.37B
totalCashPerShare 3249.667
EBITDA 44.74B
Total Debt 0.00
quickRatio 4.193
currentRatio 5.157
Total Revenue 320.38B
debtToEquity
Revenue/Share 977.052
ROA 0.01211
ROE 0.013049999
grossProfits
freeCashflow
operatingCashflow
earningsGrowth -0.71
revenueGrowth 0.005
grossMargins 0.5717
ebitdaMargins 0.13965
operatingMargins 0.03179
profitMargins 0.02628
enterpriseValue -240.01B
forwardPE
floatShares 81.97M
sharesOutstanding 12.00
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.0
heldPercentInstitutions 4014.33%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 634.466
Price To Book help_outline 0.02
earningsQuarterlyGrowth -0.71
netIncomeToCommon 8.42B
trailingEps 0.17%
forwardEps
enterpriseToEbitda -5.37
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 2
lastUpdated July 29, 2024, 7:54 a.m.